Health
Inhibition of Meprin Β enzyme can trigger the development of Alzheimer’s disease, cancer – News-Medical.Net
Researchers at Johannes Gutenberg University Mainz (JGU) in Germany and the Institute of Molecular Biology of Barcelona in Spain have discovered how the blood plasma…
Researchers at Johannes Gutenberg University Mainz (JGU) in Germany and the Institute of Molecular Biology of Barcelona in Spain have discovered how the blood plasma protein fetuin-B binds to the enzyme meprin β and used a computer model to visualize their findings.
These results could lead to the development of new drugs to treat serious diseases such as Alzheimer’s and cancer. Meprin β releases proteins from cell membranes, thus controlling important physiological functions in the human body.
…
-
Business20 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News20 hours agoRent changes on way for hundreds of social housing recipients following government review
-
Business16 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News19 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses